Sino Biological Launches 4RISE Binder Validation Services
Sino Biological's new 4RISE services provide high-throughput wet-lab validation for protein binders designed by AI.
Updated on Nov. 16, 2026 in Biotech

Sino Biological has launched 4RISE, a set of high-throughput wet-lab validation services for AI-designed protein binders. The services pair its XPressMAX cell-free protein synthesis platform with high-throughput binding screening to deliver sequence-to-binding data in as little as three days.
Why it matters
The launch addresses the gap between computational protein design and experimental confirmation, offering AI developers a route to test designed binders in the lab. Structured binding data are made available in real time via API, which may speed iteration between design and testing.
Sino Biological reports its XPressMAX cell-free platform synthesizes protein in three hours with over 99% expression success in established workflows, and 4RISE returns sequence-to-binding data in as little as three days. The company does not publish comparative benchmarks against other screening platforms, and independent validation of these figures is not described.
The players
Sino Biological
Sino Biological is a biotechnology company that supplies recombinant proteins, antibodies, and related reagents and services for research and drug development.
The details
The 4RISE offering comprises four screening services: rapid hit discovery, comparative binder screening, affinity and kinetic characterisation, and specialised binder expression and validation. It uses Carterra high-throughput SPR, Biacore SPR, and Octet BLI for binding screening, and provides more than 20 developability assays, over 1,000 protein bioactivity assays, and more than 10 cell-based functional assays. Sino Biological says the wet-lab validation has supported studies published in Science, Nature Communications, and Scientific Reports.
Timeline
• November 16, 2026: Sino Biological announces the 4RISE services.
Roadmap
The launch extends cell-free protein synthesis, the XPressMAX approach, into a full sequence-to-binding workflow aimed at AI-designed binders. It positions wet-lab validation as a service layer for computational protein design, a segment that has grown as AI tools generate candidate binders faster than they can be tested.
Researchers designing protein binders with AI tools can send candidates for experimental testing and receive binding data in about three days through API access. Teams without in-house cell-free or SPR capacity gain an outsourced route to confirm computational designs.
The takeaway
Computational protein design still depends on experimental confirmation, so faster validation services can shorten the cycle between designing a binder and knowing whether it works. Researchers evaluating such services should look for independent performance data alongside vendor-reported figures.
Further reading
Explore more Biotech news and analysis on how laboratory validation is keeping pace with AI-driven protein design.



